Ark Genomic Revolution Ucits ETF AccumUSD (ARKG.L) Dividend Yield, History & Forecast

Ark Genomic Revolution Ucits ETF AccumUSD (ARKG.L) is an exchange-traded fund (ETF) listed on the London Stock Exchange. market capitalization is approximately $102M.

ARKG.L fund composition

ARKG.L holds 32 positions. It charges an expense ratio of 0.75%, and manages $109.7M.

Sector allocation

Healthcare100.0%

Frequently Asked Questions about Ark Genomic Revolution Ucits ETF AccumUSD (ARKG.L)

What does Ark Genomic Revolution Ucits ETF AccumUSD invest in?
The investment objective of the Fund is to generate long term capital growth (5 years or more)